Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2000
10/25/2000CN1057690C Chinese patent medicine for curing oophoroma
10/25/2000CN1057689C Chuanyusan-granule for curing asthmoid
10/25/2000CN1057686C Powder medicine for otitis
10/25/2000CN1057682C Drug for curing toxocariasis
10/25/2000CN1057681C Lithagogue medicine composition
10/25/2000CN1057679C Traditional Chinese medicines antiphthitic preparation
10/25/2000CN1057676C Medicine for encephalatrophy and preparing method
10/25/2000CN1057672C Medicine for curing cerebrovascular disease
10/24/2000US6137195 Rotary-linear actuator
10/24/2000US6136989 Adding acetone to paclitaxel extract to form acetone mixture; contacting acetone mixture with aqueous solvent to form precipitate; recovering precipitate
10/24/2000US6136865 Method for reduction of the infectiousness of potentially infectious material
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136586 Methods for the selective modification of viral nucleic acids
10/24/2000US6136572 Recombinant KAT enzyme and process for its preparation
10/24/2000US6136307 Reovirus for the treatment of cellular proliferative disorders
10/24/2000US6136306 Treatment of a mammalian patient having a tumor by administering to the patient allogenic donor lymphocytes that have been co-cultured in the presence of the patient-derived lymphocytes under conditions sufficient to alloactivate the
10/24/2000CA2185535C A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
10/21/2000CA2269487A1 Improved skin treatment compositions comprising unoxidized nerve tissue
10/20/2000CA2306355A1 Methods and compositions for treating human cells
10/19/2000WO2000062063A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000WO2000061804A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061742A2 Treatment of cardiac power failure using s100 proteins
10/19/2000WO2000061736A2 Recombinant and mutant marek's disease virus
10/19/2000WO2000061726A1 Composition for the preservation of infectious recombinant adenoviruses
10/19/2000WO2000061724A2 Anti-bacterial vaccine compositions
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061617A2 Transiently immortalized cells for use in gene therapy
10/19/2000WO2000061616A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2000WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000WO2000061256A1 Method and apparatus for producing platelet rich plasma and/or platelet concentrate
10/19/2000WO2000061204A1 Three-dimensional stromal tissue
10/19/2000WO2000061190A2 Treatment of intracellular infection
10/19/2000WO2000061181A1 USE OF mCRP TO ENHANCE IMMUNE RESPONSES
10/19/2000WO2000061180A2 Products and methods for treating ptp lar related diseases
10/19/2000WO2000061170A2 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
10/19/2000WO2000061158A2 Method for renewing living being permantly
10/19/2000WO2000061156A2 Methods of treating schizophrenia
10/19/2000WO2000060950A1 Dietary supplement derived from fermented milks for the prevention of osteoporosis
10/19/2000WO2000060935A1 Method of cryopreservation of blood vessels by vitrification
10/19/2000WO2000034780A3 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
10/19/2000WO2000032224A3 Calcitonin for the modulation of sperm function
10/19/2000WO2000032208A3 Isolated material having an anti-organotrophic effect
10/19/2000WO2000029551A3 Cells, culture methods, and their use in autologous transplantation therapy
10/19/2000WO2000029550A9 Low oxygen culturing of central nervous system progenitor cells
10/19/2000WO2000024437A3 Textured and porous silicone rubber
10/19/2000DE19916352A1 Entfernung von hüllehaltigen Viren aus Blut, Plasma oder Serum Distance from cases containing viruses from blood, plasma or serum
10/19/2000DE19915485A1 Therapie der Herzinsuffizienz Treatment of heart failure
10/19/2000DE19915465A1 Verwendung eines Caspase-Inhibitors zur Proliferationshemmung von Zellen und Verwendung eines oder mehrerer Caspase-Inhibitors/en zur Behandlung von Erkrankungen beruhend auf Lymphozyten-Hyperproliferation oder zur Suppression einer Immunantwort durch Lymphozyten Using a Caspase inhibitor for the inhibition of proliferation of cells and using one or more caspase inhibitor / s for the treatment of diseases based on lymphocyte hyperproliferation or for suppression of an immune response by lymphocytes
10/19/2000CA2760534A1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000CA2372078A1 Treatment of intracellular infection
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370237A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000CA2369827A1 Separation of plasma components
10/19/2000CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000CA2369472A1 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
10/19/2000CA2369439A1 Methods of treating schizophrenia
10/19/2000CA2368884A1 Method of cryopreservation of blood vessels by vitrification
10/19/2000CA2366520A1 Anti-bacterial vaccine compositions
10/19/2000CA2365945A1 Products and methods for treating ptp lar related diseases
10/19/2000CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000CA2365901A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000CA2364562A1 Composition for the preservation of infectious recombinant adenoviruses
10/19/2000CA2364541A1 Genes associated with diseases of the kidney
10/19/2000CA2364536A1 Fragments of virus protein 2 or 3 of polyoma virus, as vehicules for active substances
10/19/2000CA2269364A1 Treatment of inflammatory and allergic disorders
10/18/2000EP1045024A1 Use of human hepatocyte cell line for the treatment of chronic or acute liver failure
10/18/2000EP1044696A2 Removal of enveloped viruses from blood, plasma or serum
10/18/2000EP1044280A1 SELECTIVE KILLING AND DIAGNOSIS OF p53?+ NEOPLASTIC CELLS
10/18/2000EP1044277A2 Recombinant, active caspases and uses thereof
10/18/2000EP1044274A2 Adenoviral vectors with modified capsid proteins
10/18/2000EP1044266A2 Human signal peptide-containing proteins
10/18/2000EP1044263A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
10/18/2000EP1044024A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site
10/18/2000EP1044020A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/18/2000EP1044009A2 Methods and compositions employing red rice fermentation products
10/18/2000EP1044004A1 A2a adenosine receptor agonists in combination with a type iv phosphodiesterase inhibitors
10/18/2000EP1043928A1 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells
10/18/2000EP0706368B1 Anti-acne composition containing a poria cocos wolf extract
10/18/2000CN1270635A Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these protein
10/18/2000CN1270630A Method of treating leukocytes, leukocyte compositions and methods of use thereof
10/18/2000CN1270527A Use of neurotoxin therapy for treatment of urologic and related disorders
10/18/2000CN1270055A Medical capsule for treating bone rheumatism and preparing process
10/18/2000CN1270054A Chinese patent medicine for treating prostatic diseases
10/18/2000CN1270052A Medicinal composition for relieving sexual fatigue and delaying sanility and preparing process thereof
10/18/2000CN1270042A 'Yuxianan' capsule
10/18/2000CN1270040A Anti-cancer Chinese-medicinal pill
10/18/2000CN1270039A Chewing tablets of pilose antler, deerhorn and deer bone and preparing process thereof
10/18/2000CN1270038A Fumigant lotion for treating anorectal disease and preparing process thereof
10/18/2000CN1269985A Health-care food for preventing electronic pollution
10/18/2000CN1269973A Hypoglycemic nutritive cracker and its making method
10/18/2000CN1057563C Bacterial stain of bacillus subtilis and application thereof
10/18/2000CN1057469C Anti-lung cancer medicine
10/18/2000CN1057466C Capsule for improving blood circulation and reducing fat
10/18/2000CN1057463C Pus drawing-out ointment
10/18/2000CN1057460C Fukang granule for women and its prepn.
10/18/2000CN1057458C Medicinal preparation for purpura
1 ... 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 ... 1259